News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,020 Results
Type
Article (23245)
Company Profile (107)
Press Release (209668)
Multimedia
Podcasts (42)
Webinars (4)
Section
Business (58044)
Career Advice (220)
Deals (9019)
Drug Delivery (68)
Drug Development (44321)
Employer Resources (24)
FDA (5525)
Job Trends (5296)
News (114136)
Policy (9868)
Tag
Academia (1348)
Academic (1)
Accelerated approval (6)
Adcomms (14)
Allergies (24)
Alliances (17812)
ALS (65)
Alzheimer's disease (682)
Antibody-drug conjugate (ADC) (130)
Approvals (5535)
Artificial intelligence (91)
Autoimmune disease (19)
Automation (9)
Bankruptcy (74)
Best Places to Work (4724)
BIOSECURE Act (7)
Biosimilars (61)
Biotechnology (89)
Bladder cancer (50)
Brain cancer (20)
Breast cancer (200)
Cancer (1913)
Cardiovascular disease (66)
Career advice (183)
Career pathing (4)
CAR-T (176)
Cell therapy (496)
Cervical cancer (16)
Clinical research (34713)
Collaboration (455)
Company closure (1)
Compensation (141)
Complete response letters (11)
COVID-19 (1202)
CRISPR (44)
C-suite (110)
Cystic fibrosis (66)
Data (1451)
Denatured (9)
Depression (11)
Diabetes (103)
Diagnostics (2246)
Digital health (5)
Diversity, equity & inclusion (7)
Drug discovery (61)
Drug pricing (98)
Drug shortages (3)
Duchenne muscular dystrophy (56)
Earnings (21206)
Editorial (18)
Employer branding (3)
Employer resources (24)
Events (35921)
Executive appointments (259)
FDA (6180)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (327)
Gene editing (94)
Generative AI (7)
Gene therapy (280)
GLP-1 (244)
Government (1451)
Grass and pollen (1)
Guidances (79)
Healthcare (6909)
Huntington's disease (9)
IgA nephropathy (15)
Immunology and inflammation (83)
Indications (20)
Infectious disease (1260)
Inflammatory bowel disease (69)
Inflation Reduction Act (9)
Influenza (17)
Intellectual property (44)
Interviews (46)
IPO (4616)
IRA (42)
Job creations (797)
Job search strategy (155)
Kidney cancer (11)
Labor market (5)
Layoffs (185)
Leadership (1)
Legal (1615)
Liver cancer (60)
Lung cancer (336)
Lymphoma (161)
Machine learning (4)
Management (7)
Manufacturing (152)
MASH (20)
Medical device (2300)
Medtech (2304)
Mergers & acquisitions (4631)
Metabolic disorders (233)
Multiple sclerosis (63)
NASH (3)
Neurodegenerative disease (54)
Neuropsychiatric disorders (11)
Neuroscience (964)
NextGen: Class of 2025 (2091)
Non-profit (1343)
Now hiring (9)
Obesity (109)
Opinion (92)
Ovarian cancer (71)
Pain (22)
Pancreatic cancer (52)
Parkinson's disease (77)
Partnered (11)
Patents (103)
Patient recruitment (65)
Peanut (14)
People (16356)
Pharmaceutical (17)
Pharmacy benefit managers (6)
Phase I (13125)
Phase II (15842)
Phase III (10190)
Pipeline (779)
Policy (88)
Postmarket research (835)
Preclinical (6104)
Press Release (57)
Prostate cancer (67)
Psychedelics (8)
Radiopharmaceuticals (119)
Rare diseases (249)
Real estate (1476)
Recruiting (8)
Regulatory (7846)
Reports (20)
Research institute (1292)
Resumes & cover letters (33)
Rett syndrome (4)
RNA editing (6)
RSV (17)
Schizophrenia (20)
Series A (65)
Series B (33)
Service/supplier (2)
Sickle cell disease (61)
Special edition (8)
Spinal muscular atrophy (103)
Sponsored (13)
Startups (1364)
State (1)
Stomach cancer (12)
Supply chain (23)
Tariffs (16)
The Weekly (31)
Vaccines (313)
Venture capitalists (16)
Weight loss (68)
Women's health (12)
Worklife (2)
Date
Today (47)
Last 7 days (447)
Last 30 days (1618)
Last 365 days (14329)
2025 (5532)
2024 (15528)
2023 (17336)
2022 (21878)
2021 (22650)
2020 (20152)
2019 (15397)
2018 (11698)
2017 (11436)
2016 (10648)
2015 (12681)
2014 (8718)
2013 (7234)
2012 (7399)
2011 (7278)
2010 (6334)
Location
Africa (160)
Alabama (18)
Alaska (3)
Arizona (43)
Arkansas (5)
Asia (15687)
Australia (2929)
California (2848)
Canada (722)
China (323)
Colorado (102)
Connecticut (81)
Delaware (90)
Europe (33112)
Florida (301)
Georgia (71)
Idaho (23)
Illinois (189)
India (8)
Indiana (57)
Iowa (5)
Japan (86)
Kansas (20)
Kentucky (8)
Louisiana (6)
Maine (45)
Maryland (383)
Massachusetts (2397)
Michigan (46)
Minnesota (127)
Missouri (30)
Montana (9)
Nebraska (9)
Nevada (22)
New Hampshire (28)
New Jersey (809)
New Mexico (15)
New York (894)
North Carolina (369)
North Dakota (9)
Northern California (1273)
Ohio (88)
Oklahoma (7)
Oregon (8)
Pennsylvania (608)
Puerto Rico (3)
Rhode Island (19)
South America (273)
Southern California (1064)
Tennessee (16)
Texas (494)
United States (10480)
Utah (68)
Virginia (58)
Washington D.C. (17)
Washington State (360)
West Virginia (1)
Wisconsin (23)
233,020 Results for "cell medica".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
·
6 min read
·
BioSpace Insights
FDA
Cell and Gene Therapy Sector Enters ‘Critical’ Period After Marks’ FDA Exit
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that Marks’ legacy will carry on.
April 28, 2025
·
7 min read
·
Heather McKenzie
Mergers & acquisitions
AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and Gracell Biotechnologies.
March 17, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
Deals
Donaldson Enters into Agreement to Acquire Minority Stake in Medica, S.p.A.
Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Company to purchase a 49% stake in Medica S.p.A.
April 29, 2024
·
5 min read
Press Releases
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
November 1, 2024
·
4 min read
Press Releases
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
April 9, 2025
·
6 min read
Business
Adaptimmune Raises ‘Substantial Doubt’ About Business Despite First-in-Class T Cell Therapy
Adaptimmune is rolling out its T cell therapy Tecelra for synovial sarcoma, recording $1.2 million in sales since its approval in August 2024. Nevertheless, it is pausing development of two oncology assets to save money.
March 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Deals
AbbVie Triples Down on T Cell Therapies in Xilio Deal Worth Up to $2.1B
The pharma giant inked its third T cell engager deal of 2025 Wednesday—this time with Xilio Therapeutics for tumor-activated immunotherapies.
February 12, 2025
·
1 min read
·
Kate Goodwin
1 of 23,302
Next
